Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,124,446    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,063,295      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,033 Incyte Corp $884,650 Immunome Inc. $105,315 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,033 Incyte Corp $884,650 Immunome Inc. $105,315
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 31 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-12 4 AS $91.44 $365,770 D/D (4,000) 328,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-08-16 4 AS $91.49 $3,811,868 D/D (41,666) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-15 4 D $91.50 $451,278 D/D (4,932) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-08 4 AS $91.72 $1,834,400 D/D (20,000) 298,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-17 4 AS $91.73 $458,650 D/D (5,000) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-27 4 AS $91.78 $367,120 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-16 4 AS $91.96 $459,800 D/D (5,000) 190,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-30 4 AS $92.02 $4,888,780 D/D (53,125) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-06-04 4 D $92.07 $580,962 D/D (6,310) 284,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-10 4 AS $92.28 $1,384,200 D/D (15,000) 487,856 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-15 4 D $92.50 $1,451,325 D/D (15,690) 190,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-11-01 4 AS $92.55 $370,200 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-01-18 4 A $92.60 $3,704 D/D 40 419,602 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-12-14 4 AS $92.64 $185,280 D/D (2,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-13 4 AS $92.68 $463,400 D/D (5,000) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-07-18 4 AS $92.72 $3,863,272 D/D (41,666) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-12-12 4 AS $93.12 $186,240 D/D (2,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-08 4 AS $93.17 $465,850 D/D (5,000) 238,496 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-05 4 AS $93.37 $280,114 D/D (3,000) 324,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-16 4 D $93.41 $8,278,274 D/D (88,623) 425,896 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-13 4 AS $93.42 $280,253 D/D (3,000) 328,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-29 4 AS $93.65 $4,974,901 D/D (53,125) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-14 4 AS $93.79 $375,160 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-12 4 D $93.93 $3,755,415 D/D (39,981) 432,732 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-03 4 D $93.95 $844,517 D/D (8,989) 206,364 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31  32   33   34      
  Page 31 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us